News & Updates
Reflexion Health, a provider of rehabilitation medicine software platform, received $7.5M in Series A Preferred Stock financing, from the Gary and Mary West Health Investment Fund. Reflexion’s Vera is a Microsoft Kinect based physical therapy program that makes rehabilitation more interactive.
BioClinica, a provider of specialized outsourced clinical trial, renewed multi-year contracts with two major pharmaceutical companies, to provide cloud-based technologies and professional services across BioClinica’s full eClinical product suite. The contracts are valued at $30M.
AirStrip, a provider of mobile healthcare solutions, acquired Sense4Baby, a developer of wireless fetal/maternal monitoring system to perform non-stress testing (NST) for high-risk pregnancies. Airstrip also licensed the associated technology from the Gary and Mary West Health Institute.
Thanks to the Health 2.0 Berlin Chapter for this newsbite: Originally developed by University of Dresden, the web-based Caterna Vision Therapy, which uses gamification to provide eye therapy for specific visual impairments, will be reimbursed by BARMER GEK, a nationwide statutory health insurance. The program will be avaiable through a partnership with Ocunet, a nationwide association of eye care centers and practices.
Medicity earned a patent for its technology for connecting referral networks and another for its technology to centralize communications between providers and patients using cloud-based mobile technology.
TrueVault, a health care app data security startup, closed $2.5 million in seed funding. TrueVault, which currently has 300 customers, provides a secure API for health care apps to use when storing sensitive patient data, and charges its clients $0.001 per API call.
PatientsLikeMe partnered with the Robert Wood Johnson Foundation to allow patients to apply to lead the development of new health outcome measurements using the company’s Open Research Exchange platform.
Everyday Health raised more than $100 million in its initial public offering, but shares fell after its premiere on the New York Stock Exchange. The New York company offered nearly 7.2 million shares at $14. The underwriters have a 30-day option to buy an additional 1.1 million shares, which would push the offering above $115 million.